Search: onr:"swepub:oai:DiVA.org:uu-520028" >
Local and Systemic ...
Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
-
- Andersson, Maria (author)
- Karolinska Institutet,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden.
-
- Wu, Jinghua (author)
- Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.
-
- Wullimann, David (author)
- Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.
-
show more...
-
- Gao, Yu (author)
- Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.
-
- Åberg, Mikael (author)
- Uppsala universitet,Klinisk kemi,Science for Life Laboratory, SciLifeLab
-
- Muschiol, Sandra (author)
- Karolinska Institutet,Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.;Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
-
- Healy, Katie (author)
- Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.
-
- Naud, Sabrina (author)
- Karolinska Inst, Dept Dent Med, Huddinge, Sweden.
-
- Bogdanovic, Gordana (author)
- Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden.;Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
-
- Palma, Marzia (author)
- Karolinska Institutet,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden.
-
- Mellstedt, Hakan (author)
- Karolinska Institutet,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.
-
- Chen, Puran (author)
- Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.
-
- Ljunggren, Hans-Gustaf (author)
- Karolinska Institutet,Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.
-
- Hansson, Lotta (author)
- Karolinska Institutet,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden.
-
- Sallberg Chen, Margaret (author)
- Karolinska Institutet,Karolinska Inst, Dept Dent Med, Huddinge, Sweden.
-
- Buggert, Marcus (author)
- Karolinska Institutet,Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden.
-
- Ingelman-Sundberg, Hanna M. (author)
- Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden.;Karolinska Univ, Hosp Solna, Dept Oncol, SE-17176 Stockholm, Sweden.
-
- Osterborg, Anders (author)
- Karolinska Institutet,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.;Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden.
-
show less...
-
Karolinska Institutet Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden;Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden. (creator_code:org_t)
- Elmer Press, Inc. 2023
- 2023
- English.
-
In: Journal of Hematology. - : Elmer Press, Inc.. - 1927-1212 .- 1927-1220. ; 12:4, s. 170-175
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Background: Patients with chronic lymphocytic leukemia (CLL) are vulnerable to coronavirus disease 2019 (COVID-19) and are at risk of inferior response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, especially if treated with the first-generation Bruton’s tyrosine kinase inhibitor (BTKi) ibrutinib. We aimed to evaluate the impact of the third-generation BTKi, zanubrutinib, on systemic and mucosal response to SARS-CoV-2 vaccination.Methods: Nine patients with CLL with ongoing zanubrutinib therapy were included and donated blood and saliva during SARS-CoV-2 vaccination, before vaccine doses 3 and 5 and 2 - 3 weeks after doses 3, 4, and 5. Ibrutinib-treated control patients (n = 7) and healthy aged-matched controls (n = 7) gave blood 2 - 3 weeks after vaccine dose 5. We quantified reactivity and neutralization capacity of SARS-CoV-2-specific IgG and IgA antibodies (Abs) in both serum and saliva, and reactivity of T cells activated with viral peptides.Results: Both zanubrutinib- and ibrutinib-treated patients had significantly, up to 1,000-fold, lower total spike-specific Ab levels after dose 5 compared to healthy controls (P < 0.01). Spike-IgG levels in serum from zanubrutinib-treated patients correlated well to neutralization capacity (r = 0.68; P < 0.0001) and were thus functional. Mucosal immunity (specific IgA in serum and saliva) was practically absent in zanubrutinib-treated patients even after five vaccine doses, whereas healthy controls had significantly higher levels (tested in serum after vaccine dose 5) (P < 0.05). In contrast, T-cell reactivity against SARS-CoV-2 peptides was equally high in zanubrutinib- and ibrutinib-treated patients as in healthy control donors.Conclusions: In our small cohort of zanubrutinib-treated CLL patients, we conclude that up to five doses of SARS-CoV-2 vaccination induced no detectable IgA mucosal immunity, which likely will impair the primary barrier defence against the infection. Systemic IgG responses were also impaired, whereas T-cell responses were normal. Further and larger studies are needed to evaluate the impact of these findings on disease protection.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Immunology in the medical area (hsv//eng)
Keyword
- CLL
- Zanubrutinib
- SARS-CoV-2
- Immunity
- Vaccination
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Andersson, Maria
-
Wu, Jinghua
-
Wullimann, David
-
Gao, Yu
-
Åberg, Mikael
-
Muschiol, Sandra
-
show more...
-
Healy, Katie
-
Naud, Sabrina
-
Bogdanovic, Gord ...
-
Palma, Marzia
-
Mellstedt, Hakan
-
Chen, Puran
-
Ljunggren, Hans- ...
-
Hansson, Lotta
-
Sallberg Chen, M ...
-
Buggert, Marcus
-
Ingelman-Sundber ...
-
Osterborg, Ander ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Infectious Medic ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Immunology in th ...
- Articles in the publication
-
Journal of Hemat ...
- By the university
-
Uppsala University
-
Karolinska Institutet